52 North Health and University of Cambridge awarded £200,000 to help translate research
52 North Health and the University of Cambridge have been awarded £200,000 under Innovate UK’s Knowledge Transfer Partnership (KTP) programme.
Flusso engineer wins major research award
Dr Ethan Gardner, one of the youngest R & D engineers with Cambridge-based fabless semiconductor company Flusso – a Cambridge University spin-out – has won a major UK honour.
Psyomics wins £2.4m to broaden mental health platform across NHS
Cambridge healthtech company Psyomics has closed a £2.4 million funding round as it continues to expand access to its online mental health assessment platform to individual users and NHS trusts.
Crowd-funding publisher Unbound appoints new CEO
Unbound, the award-winning independent crowd-funding publisher, has enjoyed a year of remarkable growth and appointed a new CEO: Wil Harris.
Tripism experiences rapid growth as return to travel brings challenges and opportunities for the corporate travel industry
Tripism, the business travel planning and engagement platform, is reporting exponential user growth as corporate travel teams scramble to deal with the rapid return to business travel in 2022.
Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer
Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors.
CyberSmart Partners with Vodafone Ireland to Enable Secure Connectivity for SMEs
CyberSmart, a UK leader in simple and accessible automated cybersecurity technology for small and medium sized enterprises (SMEs), has today announced its strategic partnership with Vodafone Ireland.
Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery
Axol Bioscience Ltd., an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announces that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.
Thought Machine launches cards and payments processing platform
UK core banking vendor Thought Machine has launched a cloud-native cards and payments processing platform.
Offshore tech firm Rovco adds new ship to fleet after deal
The Bristol subsea technology company has signed a charter agreement with Glomar Offshore
Privitar and Denodo have joined forces to bring together data’s context and regulatory compliance
In order to improve the data integration and administration capabilities of Denodo, data privacy watchdog Privitar has teamed up with the data virtualization pioneer Denodo.
Incubators for Ukraine as premature births rise
More than 50 incubators partly funded by Jersey Overseas Aid are going to hospitals across Ukraine
PharmEnable announces multi-target collaboration with Denali Therapeutics in neurodegenerative disease
PharmEnable is delighted to announce a collaboration with Denali Therapeutics, a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases.
Eagle Genomics joins Nordic life science initiative
Eagle Genomics, the Cambridge software business pioneering the application of network science to biology, has joined Medicon Valley Alliance (MVA) – a non-profit membership organisation in the Danish-Swedish life science cluster in Medicon Valley.
Chairman hails transformational year for Arecor
Cambridge’s AIM-quoted biopharma group Arecor Therapeutics saw its share price shoot 13p (3.45 per cent) higher to 393p after non-exec chair Dr Andy Richards delivered an upbeat pre-AGM statement.
Stamp Free raises £600k from global backers in oversubscribed round
Digital postage company Stamp Free Ltd, with operations in Cambridge and Edinburgh, has raised £600k in an oversubscribed funding round as it edges closer to the commercial launch of its AI phone-based alternative to traditional mailing and returns.
Thought Machine Raises $160m in Series D Funding Round – Doubling Valuation to $2.7bn and Accelerating Plans to Bring World’s Banks Onto Cloud Technology
Thought Machine, the cloud native banking technology company, today announces it has closed its series D funding round, led by Temasek, the global investment company headquartered in Singapore, with participation from Intesa Sanpaolo and Morgan Stanley.
Can I see you in my office? The pros, and the cons, of taking your business fully remote
Two years post-COVID, SMEs are still adjusting to the rapid rise of remote-working. We hear from two business owners with opposing views on the subject.
Dogtooth takes robots to Downing Street
Strawberry-harvesting-robot manufacturer Dogtooth Technologies stressed UK growers’ urgent need for labour when it showed its intelligent machines to Boris Johnson
Syndicate Room to back over 50 start-ups a year
By investing in ESG companies and lowering the EIS investment threshold, Syndicate Room is allowing more investors and start-ups to make a global impact